These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28668869)

  • 1. Clinical Outcomes of Resectable Esophageal Cancer with Supraclavicular Lymph Node Metastases Treated with Curative Intent.
    Honma Y; Hokamura N; Nagashima K; Sudo K; Shoji H; Iwasa S; Takashima A; Kato K; Hamaguchi T; Boku N; Umezawa R; Ito Y; Itami J; Koyanagi K; Igaki H; Tachimori Y
    Anticancer Res; 2017 Jul; 37(7):3741-3749. PubMed ID: 28668869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of definitive chemo-radiotherapy for esophageal cancer with supra-clavicular node metastasis based on CT in a single institutional retrospective study: a propensity score matching analysis.
    Xu HY; Wu SX; Luo HS; Chen CY; Lin LX; Huang HC
    Radiat Oncol; 2018 Oct; 13(1):200. PubMed ID: 30326912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Importance of Supraclavicular Lymph Node Metastasis After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
    Miyata H; Yamasaki M; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg; 2015 Aug; 262(2):280-5. PubMed ID: 25211269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
    Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
    Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
    Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation.
    Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; van Laarhoven HW; Hulshof MC
    Acta Oncol; 2017 Jan; 56(1):33-38. PubMed ID: 27842455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supraclavicular node metastasis from thoracic esophageal carcinoma: A surgical series from a Japanese multi-institutional nationwide registry of esophageal cancer.
    Tachimori Y; Ozawa S; Numasaki H; Matsubara H; Shinoda M; Toh Y; Udagawa H;
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1224-9. PubMed ID: 24613171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
    Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
    Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemoradiotherapy followed by oesophagectomy may be the optimal treatment option for lower thoracic oesophageal cancer with supraclavicular lymph node metastasis: An inverse probability of treatment-weighted analysis of SEER database.
    Chang X; Liu J; Zhao Y; Shi A; Yu H; Yu R; Wang W
    J Med Imaging Radiat Oncol; 2023 Sep; 67(6):676-683. PubMed ID: 37452459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
    Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma.
    Zhang HL; Chen LQ; Liu RL; Shi YT; He M; Meng XL; Bai SX; Ping YM
    Dis Esophagus; 2010 Jan; 23(1):53-8. PubMed ID: 19392846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical impact of supraclavicular lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
    Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Huang CH; Shih LH; Chen SW; Li SH
    PLoS One; 2018; 13(6):e0198800. PubMed ID: 29889869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of radiochemotherapy for solitary lymph node metastasis after curative resection of esophageal cancer.
    Jingu K; Ariga H; Nemoto K; Narazaki K; Umezawa R; Takeda K; Koto M; Sugawara T; Kubozono M; Miyata G; Onodera K; Yamada S
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):172-7. PubMed ID: 22079727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?
    Watanabe M; Mine S; Nishida K; Yamada K; Shigaki H; Matsumoto A; Sano T
    Ann Surg Oncol; 2015 Dec; 22(13):4438-44. PubMed ID: 25862582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
    Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case of Salvage Chemoradiotherapy for Regional Recurrence after Curative Esophagectomy].
    Yamamoto M; Okuno T; Imanishi T; Kanaji S; Yamashita K; Kanemitsu K; Sumi Y; Nakamura T; Suzuki S; Kakeji Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1457-9. PubMed ID: 26805062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single institutional non-randomized retrospective comparison between definitive chemoradiotherapy and radical surgery in 82 Japanese patients with resectable esophageal squamous cell carcinoma.
    Yamashita H; Nakagawa K; Yamada K; Kaminishi M; Mafune K; Ohtomo K
    Dis Esophagus; 2008; 21(5):430-6. PubMed ID: 19125797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
    Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Yano T; Muto M; Hattori S; Minashi K; Onozawa M; Nihei K; Ishikura S; Ohtsu A; Yoshida S
    Endoscopy; 2008 Sep; 40(9):717-21. PubMed ID: 18773340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.